JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumoto, S.
Right arrow Articles by Takeda, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumoto, S.
Right arrow Articles by Takeda, M.

Vol. 290, Issue 3, 974-979, September 1999

Effects of Potassium Channel Blockers on CO2-Induced Slowly Adapting Pulmonary Stretch Receptor Inhibition

Shigeji Matsumoto, Toshiaki Takahashi, Takeshi Tanimoto, Chikako Saiki and Mamoru Takeda

Department of Physiology, Nippon Dental University, School of Dentistry at Tokyo, Tokyo, Japan

In anesthetized, artificially ventilated rabbits with vagus nerve section, inhalation of CO2 gas mixtures (tracheal CO2 concentration ranging from 8.0 to 10.2%) for 60 s decreased slowly adapting pulmonary stretch receptor (SAR) activity during both inflation and deflation. The magnitude of decreased receptor activity during deflation had a more pronounced effect than that seen during inflation. CO2 inhalation did not cause any significant change in tracheal pressure (PT) as an index of bronchomotor tone. Intravenous administration of 4-aminopyridine (0.7 and 2.0 mg/kg i.v.), a K+ channel blocker, which dose-dependently increased SAR activity during deflation and had no effect on PT, abolished or attenuated the decrease in SAR activities induced by CO2 inhalation in a dose-dependent manner. The K+ channel blocker tetraethylammonium (2.0 and 6.0 mg/kg i.v.) that did not significantly alter either basal SAR discharge or PT had no effect on the inhibitory responses of receptor activity to CO2 inhalation. These results suggest that the inhibitory mechanism of CO2 inhalation on SARs may be involved in the activation of 4-aminopyridine-sensitive K+ channels in the nerve terminals of SARs.


0022-3565/99/2903-0974$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
J. W. Zhang, J. F. Walker, J. Guardiola, and J. Yu
Pulmonary sensory and reflex responses in the mouse
J Appl Physiol, September 1, 2006; 101(3): 986 - 992.
[Abstract] [Full Text] [PDF]


Home page
Chem SensesHome page
S. Matsumoto, T. Tanimoto, S. Yoshida, M. Ikeda, M. Takeda, C. Saiki, Y. Shimazu, T. Aoba, M. Nasu, and K. Suzuki
Effects of Acetazolamide and 4-Aminopyridine on CO2-induced Slowly Adapting Pulmonary Stretch Receptor Inhibition in Rats
Chem Senses, May 1, 2004; 29(4): 351 - 361.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.